Gossamer Bio Inc logo

Gossamer Bio Inc

1
NAS:GOSS (USA)  
$ 0.52 +0.0033 (+0.64%) 10:08 PM EST
At Loss
P/B:
4.41
Market Cap:
$ 117.63M
Enterprise V:
$ 82.29M
Volume:
728.53K
Avg Vol (2M):
1.56M
Trade In:
Volume:
728.53K
At Loss
Avg Vol (2M):
1.56M

Business Description

Description
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
Name Current Vs Industry Vs History
Cash-To-Debt 1.17
Equity-to-Asset 0.1
Debt-to-Equity 7.82
Debt-to-EBITDA -1.35
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 29.8
9-Day RSI 28.38
14-Day RSI 28.83
6-1 Month Momentum % -28.85
12-1 Month Momentum % -41.38

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.13
Quick Ratio 7.13
Cash Ratio 6.82

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -45
Shareholder Yield % 11.29

Financials (Next Earnings Date:2024-08-08 Est.)

GOSS's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:GOSS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Gossamer Bio Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1
Beta 2.22
Volatility % 119.18
14-Day RSI 28.83
14-Day ATR ($) 0.048962
20-Day SMA ($) 0.586615
12-1 Month Momentum % -41.38
52-Week Range ($) 0.4525 - 1.88
Shares Outstanding (Mil) 226.22

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Gossamer Bio Inc Filings

Filing Date Document Date Form
No Filing Data

Gossamer Bio Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Gossamer Bio Inc Frequently Asked Questions

What is Gossamer Bio Inc(GOSS)'s stock price today?
The current price of GOSS is $0.52. The 52 week high of GOSS is $1.88 and 52 week low is $0.45.
When is next earnings date of Gossamer Bio Inc(GOSS)?
The next earnings date of Gossamer Bio Inc(GOSS) is 2024-08-08 Est..
Does Gossamer Bio Inc(GOSS) pay dividends? If so, how much?
Gossamer Bio Inc(GOSS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1